Exacerbation of Pre-Existing Chronic Pain in Older Adults After SARS-CoV-2 Infection: A Single-Center, Cross-Sectional, Observational Study
Chenhui Wang,Lei Han,Yuru Li,Xibin Mi,Mengwei Yan,Xinxiu Yu,Yu Lu,Meihong Shi,Pengfei Liu,Liang Han,Baoguo Wang
DOI: https://doi.org/10.2147/jpr.s395042
IF: 2.8319
2024-02-13
Journal of Pain Research
Abstract:Chenhui Wang, 1 Lei Han, 2 Yuru Li, 2 Xibin Mi, 3 Mengwei Yan, 4 Xinxiu Yu, 2 Yu Lu, 2 Meihong Shi, 2 Pengfei Liu, 2 Liang Han, 2 Baoguo Wang 1 1 Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Infirmary, Taikang Yanyuan Continuing Care Retirement Community, Beijing, People's Republic of China; 3 Department of Pain Management, Yanyuan Rehabilitation Hospital, Beijing, People's Republic of China; 4 Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Capital Medical University, Beijing, People's Republic of China Correspondence: Baoguo Wang, Department of Anesthesiology, Sanbo Brain Hospital, Capital Medical University, No. 50 Yikesong Street, Haidian District, Beijing, 100095, People's Republic of China, Tel/Fax +86 10 6285 6766, Email Purpose: To identify the prevalence of exacerbation of pre-existing chronic pain after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and investigate the impact of exacerbated previous chronic pain on quality of life, sleep quality, anxiety and depression levels and risk factors associated with exacerbated chronic pain among elderly coronavirus disease of 2019 (COVID-19) survivors. Patients and Methods: In this cross-sectional study, elderly COVID-19 survivors with chronic pain residing in Continuing Care Retirement Community (CCRC) were recruited from April 2023 to June 2023. Eligible individuals were divided into exacerbation and non-exacerbation groups based on the patient-reported worsening symptoms of previous chronic pain after SARS-CoV-2 infection. Baseline information, COVID-19 symptoms, laboratory parameters, characteristics of exacerbated chronic pain, quality of life, anxiety and depression levels were systematically collected. Results: Ninety-five (95/441, 21.5%) older adults suffered from exacerbated chronic pain with a median numerical rating scale (NRS) score of 6 (4– 7) on a median duration of 4.9 (4.3– 5.6) months after SARS-CoV-2 infection. More participants were not vaccinated against COVID-19 (46.5%, 40/86 vs 26.1%, 86/330, P < 0.001) in exacerbation group. Exacerbation group exhibited poor quality of life (EQ5D index: 0.734 [0.536– 0.862] vs 0.837 [0.716– 0.942], P < 0.001), more severe anxiety (GAD-7: 2 [0– 5] vs 0 [0– 3], P < 0.001) and depression (PHQ-9: 4 [2– 7] vs 2.5 [0– 5], P < 0.001) than non-exacerbation group. Risk factors significantly associated with exacerbation of pre-existing chronic pain were neuropathic pain (aOR 4.81, 95% CI 1.73– 13.32, P = 0.003), lymphocyte count (aOR 0.31, 95% CI 0.12– 0.78, P = 0.013) and D-dimer levels (aOR 6.46, 95% CI 1.92– 21.74, P = 0.003). Conclusion: Our study observed a prevalence of 21.5% exacerbation of pre-existing chronic pain after SARS-CoV-2 infection, with a consequence of poor quality of life, more severe anxiety and depression. Previous chronic neuropathic pain, lower lymphocyte count and higher D-dimer levels were risk factors associated with the development of exacerbated previous chronic pain. Keywords: post-COVID-19, older adults, chronic pain, exacerbated symptoms After the coronavirus disease of 2019 (COVID-19) pandemic, attention has shifted towards the enduring alterations within multiple biological systems triggered by the infection of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 1,2 The distinctive manifestation of post-COVID-19 condition (PCC) was post-COVID pain and exacerbated symptoms of previous chronic pain. 3 Several observational studies have investigated the new-onset musculoskeletal pain symptoms and risk factors correlated with post-COVID pain among COVID-19 survivors. 4,5 Approximately 15.1% to 45.1% of COVID-19 survivors suffered from post-COVID pain, 6,7 and a correlation was found between prognostic serological biomarkers (eg, lymphocyte count, D-dimer levels, C-reactive protein concentration and glucose levels) and long-term post-COVID pain. 1,4 Conversely, only two studies have highlighted the exacerbation of pre-existing pain among middle-aged and hospitalized patients after SARS-CoV-2 infection, indicating a prevalence of 25.1% and 66.6%, respectively. 2,6 As the virulence and transmission of SARS-CoV-2 continue to evolve, 8 an increasing number of people are facing the problem of SARS-CoV-2 infection. Among them, the elderly are more susceptible to COVID-19 due to waning immune functions and are prone to the development of chronic pain because of troubles caused by degenerative o -Abstract Truncated-
clinical neurology